首页> 外文期刊>Orthopaedic Journal of Sports Medicine >Arthroscopic treatment of trochanteric bursitis
【24h】

Arthroscopic treatment of trochanteric bursitis

机译:关节镜治疗股骨转子滑囊炎

获取原文
获取外文期刊封面目录资料

摘要

Introduction: Trochanteric bursitis (TB) is one of the most frequent causes of hip pain. Medical treatment heals 98% of the patients. Recalcitrant cases require surgical resection. There is little evidence about the gold standard of this condition. Objective: Describe clinical results, complicactions and recurrence rate of arthroscopic treatment of TB. Methods: We included all patients who failed conservative treatment and were treated with arthroscopy for TB between March 2012 and March 2018. Patients with less than 2 years of follow up and previous surgery on the hip were excluded. We performed Ilizariturri′s technique with endoscopic resection in peritrochanteric compartment. We registered modified Harris hip score (MHHS), Hip outcome score activity of daily living (EHOSDL), patients satisfaction, recurrence rate and complications. Results: Ten patients were included. Average follow up was 40 months (range 28-60 months). MMHS improved from a preoperative average score of 70 (range 62-72) to postoperative average of 90 (range 82 to 97). Average EHOSDL improvement was 29% (from 50% preoperative to 80% postoperative). All patients had excellent results. Average patient satisfaction was 7 (range 6-9). We had no recurrence or complications. Conclusion: Arthroscopic treatment of TB allowed us to obtain very good clinical results with no complications or recurrences with a minimum 2 years follow up.
机译:简介:股骨转子滑囊炎(TB)是髋部疼痛最常见的原因之一。药物治疗可以治愈98%的患者。顽固病例需要手术切除。关于这种情况的黄金标准的证据很少。目的:描述关节镜治疗结核病的临床结果,并发症和复发率。方法:我们纳入了所有在2012年3月至2018年3月之间接受保守治疗失败并接受关节镜检查治疗的结核病患者。随访时间少于2年且以前接受过髋关节手术的患者被排除在外。我们在转子间室进行了伊丽莎白术的内镜切除术。我们记录了改良的Harris髋关节评分(MHHS),日常生活中Hip结果评分活动(EHOSDL),患者满意度,复发率和并发症。结果:包括10例患者。平均随访时间为40个月(范围28-60个月)。 MMHS从术前的平均评分70(范围62-72)提高到术后的平均评分90(范围82至97)。 EHOSDL平均改善率为29%(从术前的50%到术后的80%)。所有患者均取得良好效果。患者平均满意度为7(范围6-9)。我们没有复发或并发症。结论:关节镜治疗结核病使我们获得了非常好的临床效果,没有并发症或复发,至少需要随访2年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号